4
Changes in Ownership
Mereo BioPharma Group plc Filed Acc 0000950170-24-100281
Director sold 105,244 shares at $4.43 ($466,210)
- Director acquired 105,244 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PAKIANATHAN DEEPIKA · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-22 | Exercise or conversion : show line 1 in the form | +1,825 | $3.00 | $5,475 | 1,825 | D |
| 2024-08-22 | Exercise or conversion : show line 2 in the form | +6,492 | $1.84 | $11,945 | 8,317 | D |
| 2024-08-22 | Exercise or conversion : show line 3 in the form | +12,418 | $2.72 | $33,777 | 20,735 | D |
| 2024-08-22 | Exercise or conversion : show line 4 in the form | +38,953 | $1.31 | $51,028 | 59,688 | D |
| 2024-08-22 | Exercise or conversion : show line 5 in the form | +43,485 | $0.94 | $40,876 | 103,173 | D |
| 2024-08-22 | Exercise or conversion : show line 6 in the form | +2,071 | $3.87 | $8,015 | 105,244 | D |
| 2024-08-22 | Sale : show line 7 in the form | −105,244 | $4.43 | $466,210 | 0 | D |
| Open-market sales · 105,244 sh · avg $4.43 · $466,210 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-22 | Exercise or conversion : show line 8 in the form Share Options (right to buy) | −5,500 | 0 | D |
| 2024-08-22 | Exercise or conversion : show line 9 in the form Share Options (right to buy) | −11,000 | 0 | D |
| 2024-08-22 | Exercise or conversion : show line 10 in the form Share Options (right to buy) | −31,500 | 0 | D |
| 2024-08-22 | Exercise or conversion : show line 11 in the form Share Options (right to buy) | −55,000 | 0 | D |
| 2024-08-22 | Exercise or conversion : show line 12 in the form Share Options (right to buy) | −55,000 | 0 | D |
| 2024-08-22 | Exercise or conversion : show line 13 in the form Share Options (right to buy) | −15,000 | 30,000 | D |
Loading xslF345X05/ownership.xml…